IONIS PHARMACEUTICALS INC Quarterly Income Tax Expense (Benefit) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Ionis Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q2 2024.
  • Ionis Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $64K, a 99.2% decline year-over-year.
  • Ionis Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $13.2M, a 52% decline year-over-year.
  • Ionis Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2023 was $32.3M, a 175% increase from 2022.
  • Ionis Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2022 was $11.7M.
  • Ionis Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2021 was -$551K, a 100% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $13.2M $64K -$7.78M -99.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $21M $75K -$11.3M -99.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $32.3M $6.5M -$1.6M -19.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $33.9M $6.6M +$6.32M +2233% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $27.6M $7.84M +$5.58M +247% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $22M $11.4M +$10.3M +940% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $11.7M $8.1M +$7.8M +2609% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $3.94M $283K +$1.59M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $2.35M $2.26M +$1.93M +591% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $413K $1.09M +$964K +742% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 -$551K $299K -$341M -99.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 $340M -$1.31M -$6.37M -126% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $347M $327K -$1.76M -84.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $348M $130K +$3.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $345M $341M +$299M +706% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 $46.4M $5.06M +$20M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $26.4M $2.08M +$9.01M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $17.4M -$3.07M -$34.1M -110% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $51.5M $42.3M +$334M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 -$283M -$14.9M -$15.4M -3400% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$267M -$6.93M -$7.29M -2035% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$260M $31M +$31M +206880% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$291M -$292M -$285M -3976% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 -$6.34M $452K -$509K -53% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$5.83M $358K +$136K +61.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$5.97M $15K +$15K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$5.98M -$7.16M -$10.1M -344% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $4.12M $961K +$961K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $3.16M $222K +$453K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $2.7M $0 -$232K -100% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 $2.93M $2.93M +$2.56M +688% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $373K $0 $0 Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $373K -$231K -$1.02M -129% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $1.39M $232K +$1.02M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $372K $372K +$15.8M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 -$15.4M $0 -$1.4M -100% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$14M $789K -$92K -10.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$13.9M -$789K +$1.49M +65.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$15.4M -$15.4M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $1.4M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $881K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 -$2.28M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q3 2012 -$706K Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-06
Q1 2012 $2K $0 0% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-09
Q2 2011 $9K +$7K +350% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-06
Q1 2011 $2K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q2 2010 $2K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.